Finance

Lists
1786:TPE
SciVision Biotech Inc
NT$44,30
-4,01%
(-1,85) 1D
3 Sep., 13:30:06 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1786...
Open
NT$45,80
High
NT$45,85
Low
NT$44,30
Mkt. cap
3,31 mjd
Avg. vol.
156,39 k
Volume
546,19 k
Dividend
4,31%
Quarterly dividend
NT$0,48
Ex-dividend date
18 Jul. 2022
P/E ratio
19,23
52-wk high
NT$111,00
52-wk low
NT$44,30
EPS
NT$2,30
Shares outstanding
53,10 m
No. of employees
64
Open
NT$45,80
High
NT$45,85
Low
NT$44,30
Mkt. cap
3,31 mjd
Avg. vol.
156,39 k
Volume
546,19 k
Dividend
4,31%
Quarterly dividend
NT$0,48
Ex-dividend date
18 Jul. 2022
P/E ratio
19,23
52-wk high
NT$111,00
52-wk low
NT$44,30
EPS
NT$2,30
Shares outstanding
53,10 m
No. of employees
64
About SciVision Biotech Inc
CEO-
Employees64
Founded1990
Headquarters-
SectorMedical device
Websitescivision.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
221,41 m
251,39 m
205,32 m
211,03 m
Cost of goods sold
67,33 m
62,04 m
60,12 m
71,98 m
Cost of revenue
67,33 m
62,04 m
60,12 m
71,98 m
Research and development expenses
21,26 m
32,38 m
22,94 m
20,75 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86,38 m
107,04 m
100,96 m
89,57 m
Operating expense
107,65 m
139,42 m
123,90 m
110,32 m
Total operating expenses
174,97 m
201,46 m
184,02 m
182,30 m
Operating income
46,44 m
49,93 m
21,30 m
28,73 m
Other non operating income
2,10 m
2,19 m
1,30 m
51,00 k
EBT including unusual items
71,72 m
72,40 m
35,68 m
27,57 m
EBT excluding unusual items
71,72 m
74,54 m
35,70 m
28,60 m
Income tax expense
13,39 m
9,21 m
13,73 m
-7,08 m
Effective tax rate
18,68%
12,72%
38,47%
-25,67%
Other operating expenses
-
-
-
-
Net income
58,32 m
63,18 m
21,96 m
34,64 m
Net profit margin
26,34%
25,13%
10,69%
16,42%
Earnings per share
-
-
-
-
Interest and investment income
4,76 m
8,75 m
6,50 m
7,42 m
Interest expense
-2,43 m
-3,18 m
-3,12 m
-3,10 m
Net interest expenses
2,34 m
5,57 m
3,37 m
4,32 m
Depreciation and amortization charges
-
-
-
-
EBITDA
63,95 m
68,84 m
41,06 m
49,04 m
Gain or loss from assets sale
-
10,00 k
16,00 k
-23,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme